Granisetron transdermal delivery system is effective in the control of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy (MEC) or highly emetogenic chemotherapy (HEC) in China.
暂无分享,去创建一个
[1] J. Ahn,et al. A randomized study of the efficacy and safety of transdermal granisetron in the control of nausea and vomiting induced by moderately emetogenic chemotherapy in Korean patients , 2015, Supportive Care in Cancer.
[2] S. Grunberg,et al. Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study , 2010, Supportive Care in Cancer.
[3] L. Schulmeister. Granisetron transdermal system: a new option to help prevent chemotherapy-induced nausea and vomiting. , 2009, Clinical journal of oncology nursing.
[4] H. Drenth,et al. Pharmacokinetics of a granisetron transdermal system for the treatment of chemotherapy-induced nausea and vomiting , 2009, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[5] F. Roila,et al. Impact of Nausea and Vomiting on Quality of Life in Cancer Patients During Chemotherapy , 2003, Health and quality of life outcomes.
[6] W. Hasler. Serotonin receptor physiology: relation to emesis. , 1999, Digestive diseases and sciences.
[7] J. Laszlo. Nausea and Vomiting as Major Complications of Cancer Chemotherapy , 1983, Drugs.
[8] A. Fauser,et al. Anti-Emetics for Cancer Chemotherapy-Induced Emesis Potential of Alternative Delivery Systems , 2012, Drugs.
[9] P. D,et al. Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists , 2004, Supportive Care in Cancer.